Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Yost

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 4, 2021
Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Cell|October 15, 2013
Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signalingGuobin He, Debanjan Dhar, Hayato Nakagawa, et al.
Journal of Geriatric Oncology|March 5, 2021
Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Cancer Discovery|August 7, 2024
Disparate Pathways for Extrachromosomal DNA Biogenesis and Genomic DNA RepairJohn C Rose, Julia A Belk, Ivy Tsz-Lo Wong, et al.
Antioxidants (Basel, Switzerland)|April 14, 2025
The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol AcetateRosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Nature Immunology|October 27, 2022
Divergent clonal differentiation trajectories of T cell exhaustionBence Daniel, Kathryn E Yost, Sunnie Hsiung, et al.
Antioxidants (Basel, Switzerland)|December 30, 2025
Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. <i>Antioxidants</i> 2025, <i>14</i>, 345Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Cancer|January 21, 2021
Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health InitiativeYuan Yuan, Kathy Pan, Joanne Mortimer, et al.
Elife|June 13, 2022
RNA-binding proteins direct myogenic cell fate decisionsJoshua R Wheeler, Oscar N Whitney, Thomas O Vogler, et al.
Nature Medicine|July 31, 2019
Clonal replacement of tumor-specific T cells following PD-1 blockadeKathryn E Yost, Ansuman T Satpathy, Daniel K Wells, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|July 4, 2021
Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Cell|October 15, 2013
Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signalingGuobin He, Debanjan Dhar, Hayato Nakagawa, et al.
Journal of Geriatric Oncology|March 5, 2021
Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Cancer Discovery|August 7, 2024
Disparate Pathways for Extrachromosomal DNA Biogenesis and Genomic DNA RepairJohn C Rose, Julia A Belk, Ivy Tsz-Lo Wong, et al.
Antioxidants (Basel, Switzerland)|April 14, 2025
The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol AcetateRosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Nature Immunology|October 27, 2022
Divergent clonal differentiation trajectories of T cell exhaustionBence Daniel, Kathryn E Yost, Sunnie Hsiung, et al.
Antioxidants (Basel, Switzerland)|December 30, 2025
Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. <i>Antioxidants</i> 2025, <i>14</i>, 345Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Cancer|January 21, 2021
Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health InitiativeYuan Yuan, Kathy Pan, Joanne Mortimer, et al.
Elife|June 13, 2022
RNA-binding proteins direct myogenic cell fate decisionsJoshua R Wheeler, Oscar N Whitney, Thomas O Vogler, et al.
Nature Medicine|July 31, 2019
Clonal replacement of tumor-specific T cells following PD-1 blockadeKathryn E Yost, Ansuman T Satpathy, Daniel K Wells, et al.
Pageof 14